POMC and erythropoietic protoporphyria: Afamelanotide, the only medication licensed for the treatment of erythropoietic protoporphyria and a first-in-class synthetic 13-amino acid peptide analog of the endogenous alpha-melanocyte-stimulating hormone, shared structural similarities with daptomycin [63,64].